Here's a look at some of the top Wall Street stories for medical device companies this week: InVivo shares soar on spinal cord study update; Actavis trumps Valeant with $66B offer for Allergan; Medtronic's Q2 results meet The Street; Venture capital investment in medtech grows in Q3
InVivo shares soar on spinal cord study update
November 13, 2014 by Val Kennedy
Actavis, InVivo Therapeutics Corp., Medtronic, National Venture Capital Assn. (NVCA), Pershing Square Capital Management, PricewaterhouseCoopers (PwC), Thomson Reuters, Valeant Pharmaceuticals, Allergan Inc.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1qzhgNn
Cap comentari:
Publica un comentari a l'entrada